PMVP - PMV Pharmaceuticals, Inc.

QQQ $ 602.14 $ 6.92 (1.16 %)

DIA $ 464.40 $ 7.39 (1.62 %)

SPY $ 665.19 $ 7.90 (1.2 %)

TLT $ 90.63 $ -0.01 (-0.01 %)

GLD $ 381.53 $ 3.29 (0.87 %)

Previous Close

$ 1.32

Open

$ 1.32

Bid

$ 1.39 x 100

Ask

$ 1.40 x 600

Day's Range

$ 1.32 - $ 1.40

52 Week Range

$ 0.81 - $ 1.84

Volume

654,189

Average Volume

Market Cap

69.95M

Beta (5Y Monthly)

$ 1.18

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-09-2025	03-31-2025	10-Q
3	03-03-2025	01-01-1970	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	03-01-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-13-2021	06-30-2021	10-Q
18	05-14-2021	03-31-2021	10-Q
19	03-03-2021	12-31-2020	10-K
20	11-13-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

PMV Pharmaceuticals To Present Rezatapopt ...
10/13/2025 20:05:46

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-N...

small-cap-pmv-pharmaceuticals-cancer-drug-shows-confirmed-responses-in-8-tumor-types

Small-Cap PMV Pharmaceuticals Cancer Drug ...
09/10/2025 19:10:20

PMV Pharma's Phase 2 trial shows 33% response in TP53 Y220C-mutated tumors, with ovarian cancer achieving a 43% response ra...

12 Health Care Stocks Moving In Wednesday'...
09/10/2025 17:07:06

12 Health Care Stocks Moving In Wednesday'...
09/10/2025 12:11:03

$pmv-pharma-announces-interim-data-from-phase-2-pivotal-portion-of-pynnacle-clinical-trial-plans-to-submit-nda-for--platinum-resistantrefractory-ovarian-cancer-by-end-of-q1-2027$

PMV Pharma Announces Interim Data From Pha...
09/10/2025 11:11:12

PYNNACLE Phase 2 pivotal clinical trial interim data include confirmed responses observed in eight tumor types spanning ovarian...

12 Health Care Stocks Moving In Monday's A...
08/25/2025 21:07:30

PMV Pharma Q2 EPS $(0.41) Misses $(0.38) E...
08/07/2025 12:43:00

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.38) ...

PMV Pharma Q1 EPS $(0.34) Beats $(0.37) Es...
05/09/2025 12:18:40

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.37) by...

HC Wainwright & Co. Reiterates Buy on PMV ...
03/20/2025 10:33:44

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

PMV Pharma FY 2024 GAAP EPS $(1.14) Misses...
03/03/2025 13:07:10

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.08) ...

PMV Pharma Q3 EPS $(0.37) Misses $(0.35) E...
11/07/2024 13:23:30

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.35) ...

PMV Pharmaceuticals Says Enrollment On Tra...
10/23/2024 12:04:25

HC Wainwright & Co. Reiterates Buy on PMV ...
08/20/2024 10:50:47

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

PMV Pharma Q2 EPS $(0.02) Beats $(0.33) Es...
08/08/2024 12:13:37

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.33) by...

HC Wainwright & Co. Reiterates Buy on PMV ...
05/30/2024 10:47:37

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

Foundation Medicine and PMV Pharma Partner...
05/29/2024 11:10:25

Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ:PMVP, ", PMV Pharma", )))) today announced a partnershi...

HC Wainwright & Co. Reiterates Buy on PMV ...
05/14/2024 10:36:24

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

Craig-Hallum Initiates Coverage On PMV Pha...
05/13/2024 16:20:16

Craig-Hallum analyst Albert Lowe initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target...

PMV Pharma Q1 EPS $(0.30) Beats $(0.37) Es...
05/09/2024 12:52:45

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by...

Jefferies Initiates Coverage On PMV Pharma...
04/12/2024 13:22:03

Jefferies analyst Kambiz Yazdi initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target o...